May 6: Repurposing Existing Medicines for COVID-19

STREAMED ON Wednesday, May 6, 2020 @ 3:30pm ET

Webinar archive coming soon!

This week, a graduate student tag team will discuss research on how protein-protein interactions between human proteins and SARS-CoV-2 can provide clues into using existing therapies for the treatment of COVID-19. The presenters will discuss the biorXiv pre-print “A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing.”

D4P Fellows:

Lindsey Lopes (she/her), Graduate Student @The Rockefeller University

Lindsey is a PhD student at The Rockefeller University in the Laboratory of Social Evolution and Behavior. She studies how ants communicate with each other using chemical signals. She is interested in how the brain is able to process these chemicals and coordinate the ant’s behavioral response. Before this, she was a student at Haverford College and University of Pennsylvania. She enjoys playing with her cats, baking, reading, and doing yoga when she is not in the lab.

Emily Costa (she/her), Graduate Student @MSKCC/Weill Cornell

Em is a 4th year PhD candidate at Weill Cornell and a lung cancer researcher at Memorial Sloan Kettering. In this role, she studies how drugs that disrupt our cell’s response to DNA damage might improve the effectiveness of immunotherapy in small cell lung cancer. Before starting grad school, Em worked at various pharma and biotech companies in the Boston area and got her undergraduate degree at Northeastern University. When she’s not in the lab, you can find her writing and podcasting about science, making cyanotypes, or tending to an ever-growing family of houseplants.